ARROWHEAD PHARMACEUTICALS, INC. — Revenue by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2d92481f-2552-416a-bb27-0ec95564daae/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $829.4M | 2024-10-01 – 2025-09-30 | evidence 0000879407-25-000029 |
| FY 2024 | $3.6M | 2023-10-01 – 2024-09-30 | evidence 0001628280-24-049277 |
| FY 2023 | $240.7M | 2022-10-01 – 2023-09-30 | evidence 0001628280-23-040219 |
| FY 2022 | $243.2M | 2021-10-01 – 2022-09-30 | evidence 0001628280-22-030869 |
| FY 2021 | $138.3M | 2020-10-01 – 2021-09-30 | evidence 0001564590-21-057888 |
| FY 2020 | $88.0M | 2019-10-01 – 2020-09-30 | evidence 0001564590-21-057888 |
| FY 2019 | $168.8M | 2018-10-01 – 2019-09-30 | evidence 0001564590-21-057888 |
| FY 2018 | $16.1M | 2017-10-01 – 2018-09-30 | evidence 0001564590-19-044376 |
| FY 2017 | $31.4M | 2016-10-01 – 2017-09-30 | evidence 0001564590-19-044376 |
| FY 2016 | $158.3k | 2015-10-01 – 2016-09-30 | evidence 0001564590-16-030217 |
| FY 2015 | $382.0k | 2014-10-01 – 2015-09-30 | evidence 0001564590-15-011489 |
| FY 2014 | $175.0k | 2013-10-01 – 2014-09-30 | evidence 0001564590-14-005961 |
| FY 2013 | $4.5M | 2003-05-01 – 2014-03-31 | evidence 0001564590-14-001816 |
| FY 2012 | $4.3M | 2003-05-01 – 2013-03-31 | evidence 0001193125-13-210998 |
| FY 2011 | $4.0M | 2003-05-07 – 2012-03-31 | evidence 0001193125-12-218387 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ARROWHEAD PHARMACEUTICALS, INC. — all facts · Net Income · Operating Income